ARCHIVES

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

In Brief: Fred Rapp to Retire, Set Sail For Europe; Armand Hammer To Celebrate 92nd Birthday

May 18, 1990